BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38584496)

  • 1. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
    Walts AE; Ines D; Marchevsky AM
    Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphometric evaluation of the Ki-67 proliferation rate and CD34 microvascular and D2-40 lymphovascular densities drives the pulmonary typical carcinoid outcome.
    de Vilhena AF; das Neves Pereira JC; Parra ER; Balancin ML; Ab Saber A; Martins V; Farhat C; Abrantes MM; de Campos JRM; Tedde ML; Takagaki T; Capelozzi VL
    Hum Pathol; 2018 Nov; 81():201-210. PubMed ID: 30031097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
    Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
    Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
    Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
    Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
    Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
    Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
    Marchevsky AM; Hendifar A; Walts AE
    Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cyclin A2 and B1 expression in lung carcinoids.
    Brcic L; Heidinger M; Sever AZ; Zacharias M; Jakopovic M; Fediuk M; Maier A; Quehenberger F; Seiwerth S; Popper H
    Pathology; 2019 Aug; 51(5):481-486. PubMed ID: 31230818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens.
    Viswanathan K; Borczuk AC; Siddiqui MT
    J Am Soc Cytopathol; 2019; 8(1):39-46. PubMed ID: 30929758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study.
    Costes V; Marty-Ané C; Picot MC; Serre I; Pujol JL; Mary H; Baldet P
    Hum Pathol; 1995 Jul; 26(7):740-5. PubMed ID: 7628845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Prinzi N; Pusceddu S; Missiato L; Colantuono M; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 May; 82(6):870-884. PubMed ID: 36720841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung.
    Garg R; Bal A; DAS A; Singh N; Singh H
    Turk Patoloji Derg; 2019; 35(1):15-21. PubMed ID: 30070306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
    Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
    Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of atypical carcinoid can be made on biopsies > 4 mm
    Reuling EMBP; Naves DD; Daniels JMA; Dickhoff C; Kortman PC; Broeckaert MAMB; Plaisier PW; Thunnissen E; Radonic T
    Virchows Arch; 2022 Mar; 480(3):587-593. PubMed ID: 35089404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.